 |
PDBsum entry 6fns
|
|
|
|
References listed in PDB file
|
 |
|
Key reference
|
 |
|
Title
|
 |
Inhibition and regulation of the ergothioneine biosynthetic methyltransferase egtd.
|
 |
|
Authors
|
 |
L.Misson,
R.Burn,
A.Vit,
J.Hildesheim,
M.A.Beliaeva,
W.Blankenfeldt,
F.P.Seebeck.
|
 |
|
Ref.
|
 |
ACS Chem Biol, 2018,
13,
1333-1342.
[DOI no: ]
|
 |
|
PubMed id
|
 |
|
 |
 |
|
Abstract
|
 |
|
Ergothioneine is an emerging factor in cellular redox homeostasis in bacteria,
fungi, plants, and animals. Reports that ergothioneine biosynthesis may be
important for the pathogenicity of bacteria and fungi raise the question as to
how this pathway is regulated and whether the corresponding enzymes may be
therapeutic targets. The first step in ergothioneine biosynthesis is catalyzed
by the methyltransferase EgtD that converts histidine into
N-α-trimethylhistidine. This report examines the kinetic, thermodynamic and
structural basis for substrate, product, and inhibitor binding by EgtD from
Mycobacterium smegmatis. This study reveals an unprecedented substrate binding
mechanism and a fine-tuned affinity landscape as determinants for product
specificity and product inhibition. Both properties are evolved features that
optimize the function of EgtD in the context of cellular ergothioneine
production. On the basis of these findings, we developed a series of simple
histidine derivatives that inhibit methyltransferase activity at low micromolar
concentrations. Crystal structures of inhibited complexes validate this
structure- and mechanism-based design strategy.
|
 |
|
|
|
|
 |